METHIONINE MARKET ANALYSIS

Key Developments

• In March 2024, Evonik announced the latest results from its global methionine trials, showcasing the efficacy and performance of its MetAMINO product. The trials, conducted across 19 different locations, demonstrated that similar animal performance was achieved when 100 units of methionine hydroxy analog products were replaced with just 65 units of MetAMINO. These findings highlight the superior quality and bioavailability of Evonik's methionine solution, providing animal producers with an opportunity to optimize their feed formulations while maintaining optimal animal health and growth.
• In 2023, Adisseo announced the construction of a new powder methionine plant in China, further consolidating its leadership in the methionine industry. This strategic investment aims to enhance production capabilities and meet the growing global demand for high-quality methionine, a vital amino acid in animal nutrition. By expanding its manufacturing footprint in China, Adisseo is reinforcing its commitment to providing innovative solutions and maintaining its competitive edge in the market.
• In 2022, Evonik announced a significant expansion project at its manufacturing facility in Theodore, Alabama, aimed at enhancing its animal nutrition business. The project focuses on the production of methyl mercaptan, a key component in the manufacture of Evonik's MetAmino (DL-methionine) product.